Catalyst
Slingshot members are tracking this event:
Lipocine (LPCN) Releases Phase 2b Results for Oral Testosterone Replacement Therapy LPCN 1111
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| LPCN |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 26, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2b Results, Oral Testosterone Replacement Therapy, Lpcn 1111
